HVR-66598-76029
2 vaccinations
1 coded response
8 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 115 / NY
- Registered
- 2021-01-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-20
Dose 1 — Pfizer-BioNTech
-
2021-01-06
Dose 2 — Pfizer-BioNTech
-
2021-01-25
Registered in v-safe
- 2021-01-25
- 2021-01-27
- 2021-02-03
- 2021-02-10
- 2021-02-17
- 2021-04-09
- 2021-07-07
-
2022-01-06
Survey response — 12 months, dose 2MedDRA: Heavy menstrual bleeding, Uterine dilation and curettage, Uterine polyp — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Heavy menstruation, uterine polyps requiring d&vMedDRA releases: 2024-11 · check-in free text available
-
2022-01-06
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-01-07
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-20 | Pfizer-BioNTech | |
| 2 | 2021-01-06 | Pfizer-BioNTech |
Call center
1 call center case
1 successful
Free text
Release 10 — 12 months, dose 2
Symptoms: Heavy menstruation, uterine polyps requiring d&v
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Heavy menstrual bleeding | · | · | ✓ |
| SD | Uterine dilation and curettage | · | · | ✓ |
| SD | Uterine polyp | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release